These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Proteomic analysis for early detection of ovarian cancer: a realistic approach? Stevens EV; Liotta LA; Kohn EC Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269 [TBL] [Abstract][Full Text] [Related]
27. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer]. Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310 [No Abstract] [Full Text] [Related]
28. Prevention and early detection of ovarian cancer: mission impossible? Bast RC; Brewer M; Zou C; Hernandez MA; Daley M; Ozols R; Lu K; Lu Z; Badgwell D; Mills GB; Skates S; Zhang Z; Chan D; Lokshin A; Yu Y Recent Results Cancer Res; 2007; 174():91-100. PubMed ID: 17302189 [TBL] [Abstract][Full Text] [Related]
29. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer. Ramalingam P Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153 [TBL] [Abstract][Full Text] [Related]
30. Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer. El Bairi K; Kandhro AH; Gouri A; Mahfoud W; Louanjli N; Saadani B; Afqir S; Amrani M Cell Oncol (Dordr); 2017 Apr; 40(2):105-118. PubMed ID: 27981507 [TBL] [Abstract][Full Text] [Related]
34. Predictive modeling in proteomics-based disease detection. Pham TD Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703 [TBL] [Abstract][Full Text] [Related]
35. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics. Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122 [TBL] [Abstract][Full Text] [Related]
36. Molecular diagnosis in type I epithelial ovarian cancer. Sadłecki P; Walentowicz-Sadłecka M; Grabiec M Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228 [TBL] [Abstract][Full Text] [Related]
37. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions. Jurisicova A; Jurisica I; Kislinger T Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466 [TBL] [Abstract][Full Text] [Related]
38. Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers. Sölétormos G; Duffy MJ; Othman Abu Hassan S; Verheijen RH; Tholander B; Bast RC; Gaarenstroom KN; Sturgeon CM; Bonfrer JM; Petersen PH; Troonen H; CarloTorre G; Kanty Kulpa J; Tuxen MK; Molina R Int J Gynecol Cancer; 2016 Jan; 26(1):43-51. PubMed ID: 26588231 [TBL] [Abstract][Full Text] [Related]
39. [Proteomics and biomarkers for detection of ovarian cancer]. Kacerovský M; Tambor V; Lenco J; Tosner J Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513 [TBL] [Abstract][Full Text] [Related]